Table 2.
Sex | Measure |
Total population (I) |
Without DM (II) |
With DM (III) |
Loss of LE associated with DM (II-III) |
Gain in LE after eliminating DM (II-I) |
---|---|---|---|---|---|---|
At birth | ||||||
Females |
LE |
83.6(83.6-83.7) |
85.0(85.0-85.1) |
74.9(74.3-75.6) |
10.1*(9.5-10.7) |
1.4* |
HALE |
72.1(71.8-72.3) |
73.3(73.0-73.5) |
62.2(60.7-63.8) |
11.1*(9.5-12.7) |
1.2* |
|
LE-HALE2 |
|
11.7* (11.4-12.0) |
12.7*(11.8-13.6) |
|
|
|
(LE-HALE)/LE3 |
|
0.14 |
0.17 |
|
|
|
Males |
LE |
78.9(78.8-78.9) |
80.2(80.2-80.3) |
70.9(70.4-71.4) |
9.3*(8.8-9.8) |
1.3* |
HALE |
69.6(69.4-69.9) |
70.9(70.7-71.2) |
60.1(58.4-61.9) |
10.8*(9.1-12.5) |
1.3* |
|
LE-HALE2 |
|
9.3*(9.1-9.5) |
10.8*(9.6-12.0) |
|
|
|
(LE-HALE)/LE3 |
|
0.12 |
0.15 |
|
|
|
At age 20 | ||||||
Females |
LE |
64.3(64.2-64.3) |
65.7(65.7-65.7) |
56.5(56.2-56.8) |
9.2*(8.9-9.5) |
1.4* |
HALE |
53.6(53.3-53.9) |
54.8(54.5-55.1) |
44.7(43.4-46.1) |
10.1*(8.7-11.5) |
1.2* |
|
LE-HALE2 |
|
10.9*(10.6-11.2) |
11.8*(10.8-12.8) |
|
|
|
(LE-HALE)/LE3 |
|
0.17 |
0.21 |
|
|
|
Males |
LE |
59.6(59.6-59.7) |
61.0(61.0-61.1) |
52.2(51.9-52.5) |
8.8*(8.5-9.1) |
1.4* |
HALE |
51.3(51.1-51.6) |
52.6(52.3-52.9) |
43.0(41.9-44.1) |
9.6*(8.5-10.7) |
1.3* |
|
LE-HALE2 |
|
8.4*(8.2-8.6) |
9.2*(8.4-10.0) |
|
|
|
(LE-HALE)/LE3 |
|
0.14 |
0.18 |
|
|
|
At age 55 | ||||||
Females |
LE |
30.6(30.6-30.6) |
32.0(31.9-32.0) |
26.0(25.9-26.1) |
6.0*(5.9-6.1) |
1.4* |
HALE |
23.6(23.4-23.9) |
24.7(24.4-25.0) |
18.9(18.3-19.6) |
5.8*(5.1-6.5) |
1.1* |
|
LE-HALE2 |
|
7.3*(7.1-7.5) |
7.1*(6.5-7.7) |
|
|
|
(LE-HALE)/LE3 |
|
0.23 |
0.27 |
|
|
|
Males |
LE |
26.8(26.7-26.8) |
28.0(28.0-28.1) |
23.0(23.0-23.1) |
5.0*(4.9-5.1) |
1.2* |
HALE |
21.6(21.4-21.8) |
22.8(22.5-23.1) |
17.5(17.0-18.1) |
5.3*(4.7-5.9) |
1.2* |
|
LE-HALE2 |
|
5.2*(5.0-5.4) |
5.5*(5.0-6.0) |
|
|
|
(LE-HALE)/LE3 |
|
0.19 |
0.24 |
|
|
|
At age 80 | ||||||
Females |
LE |
11.0(10.9-11.0) |
11.7(11.7-11.7) |
9.1(9.1-9.2) |
2.6*(2.6-2.6) |
0.7* |
HALE |
7.0(6.7-7.2) |
7.4(7.1-7.7) |
5.8(5.2-6.3) |
1.6*(0.9-2.3) |
0.4* |
|
LE-HALE2 |
|
4.3*(4.0-4.6) |
3.3*(2.8-3.8) |
|
|
|
(LE-HALE)/LE3 |
|
0.37 |
0.36 |
|
|
|
Males | LE |
8.8(8.7-8.8) |
9.4(9.3-9.4) |
7.5(7.4-7.5) |
1.9*(1.9-1.9) |
0.6* |
HALE |
5.9(5.6-6.2) |
6.4(6.1-6.8) |
4.3(3.7-5.0) |
2.1*(1.4-2.8) |
0.5** |
|
LE-HALE2 |
|
3.0*(2.7-3.3) |
3.2*(2.6-3.8) |
|
|
|
(LE-HALE)/LE3 | 0.32 | 0.43 |
* Statistically significant (p-value <0.0001).
** Statistically significant (p-value <0.05).
1Dataset excluded Quebec, Nunavut, and Northwest Territories.
2LE-HALE: years difference between life expectancy and health-adjusted life expectancy.
3(LE-HALE)/LE: the proportion of life spent in poor health.